J Breast Cancer.
2022 Dec;25(6):522. 10.4048/jbc.2022.25.e51.
Somatic Mutations of TP53 and Prognostic Factors for Primary Operable Breast Cancer: Correspondence
- Affiliations
-
- 1Private Academic Consultant, Bangkok, Thailand
- 2Department of Pharmaceutical Sciences, University Centre for Research & Development, Chandigarh University, Mohali, India
- KMID: 2537652
- DOI: http://doi.org/10.4048/jbc.2022.25.e51
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study
- Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis
- Prognostic factors of operable breast cancer
- Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer
- Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
